HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics AG (NBRV), sold 47,539 shares at $11.16 ($528K) on 2017-04-18, disclosed to the SEC on 2017-04-20.
Open-market sale of $528k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.16 | 11,822 | $132K | 25.0% |
| 2 | $11.16 | 11,822 | $132K | 25.0% |
| 3 | $11.07 | 11,785 | $130K | 24.7% |
| 4 | $11.07 | 11,785 | $130K | 24.7% |
| 5 | $11.00 | 325 | $4K | 0.7% |
| Total | $11.11 avg | 47,539 |
| $528K |
| 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |